Genital shedding of herpes simplex virus (HSV) results in frequent transmission of infection to sexual partners and neonates. In a cross-sectional study, cervical shedding of HSV DNA was detected in 43 (17%) cervical swab samples from 273 women seropositive for HSV-1, HSV-2, and human immunodeficiency virus type 1 (HIV-1). Cervical shedding of HSV was significantly associated with oral contraception (adjusted odds ratio [aOR], 4.5; 95% confidence interval [CI], 1.7-12.2), use of depo-medroxyprogesterone acetate (aOR, 3.2; 95% CI, 1.3-7.7), and pregnancy (aOR, 7.9; 95% CI, 2.0-31.7). In the subgroup of women who were not pregnant and not using hormonal contraception ( ), serum vitamin A was highly predictive of n = 178 cervical HSV shedding: concentrations indicating severe deficiency, moderate deficiency, lownormal, and high-normal status were associated with 29%, 18%, 8%, and 2% prevalences of cervical HSV shedding, respectively (linear trend, ). Several factors appear to influ-P = .0002 ence HSV reactivation in HIV-1 seropositive women.
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are highly prevalent in human populations worldwide [1] . In the United States, recent seroprevalence studies indicate that 22%-33% of the adult population is infected with HSV-2, representing a 30% increase over the past 2 decades [2, 3] . The seroprevalence of HSV-2 in many developing countries is even higher, with evidence that 50%-80% of individuals are infected in some highly sexually active populations [1] . Increasingly, HSV is being recognized as an important cause of genital ulcer disease in the developing world [4, 5] . Asymptomatic shedding of HSV occurs frequently in individuals with genital herpes and accounts for the majority of HSV infections transmitted to sexual partners and neonates [6, 7] .
Our understanding of the prevalence and patterns of HSV shedding in the genital tract has come largely from prospective studies of white women in North America [8] [9] [10] [11] . HSV has been cultured from genital tract swabs on 1%-4% of days sam-pled [8] [9] [10] [11] . These studies have identified subclinical shedding of HSV to be associated with the duration of HSV infection, pregnancy, and a high frequency of symptomatic reactivation [8] [9] [10] [11] . A more recent study used both HSV culture and polymerase chain reaction (PCR) detection of HSV DNA to detect shedding of HSV in the female genital tract; HSV cultures were positive an average of 8% of days, whereas HSV DNA was detected an average of 28% of days [12] . Two studies suggest that genital shedding of HSV may occur with higher frequency among human immunodeficiency virus type 1 (HIV-1)-infected women than among HIV-1-uninfected women [13, 14] .
In a recent cross-sectional study, we evaluated genital shedding of HIV-1 in women attending a municipal sexually transmitted disease (STD) clinic in Mombasa, Kenya [15] . The seroprevalence of HSV-1 and HSV-2 was very high in this population, which afforded the opportunity to study genital shedding of HSV. In the present study, we sought to evaluate the potential influence of contraceptive use, pregnancy, serum vitamin A levels, and concomitant STDs on cervical shedding of HSV DNA.
Methods
Study design and population. Women included in the present analysis were a subset of women recruited for a previous study of cervicovaginal HIV-1 DNA shedding [15] . Between December 1994 and April 1996, 318 HIV-1 seropositive women attending a municipal STD clinic in Mombasa, Kenya were enrolled in a large cross-sectional study [15] . Recruitment and screening of participants were described elsewhere in detail [15] . After informed consent was obtained, each participant was interviewed by use of a standardized questionnaire. She then underwent physical examination, STD screening, collection of genital tract samples for viral DNA analysis, and venipuncture for serum and EDTA-anticoagulated blood. Sera were assayed for antibodies to HIV-1 at study entrance. After the original study was completed, stored sera were assayed for antibodies to HSV-1 and HSV-2. The present analysis includes individuals who were seropositive for all 3 viruses.
Cervical secretions for viral DNA analysis was obtained by gently inserting a Dacron swab 1 cm into the cervical os and turning 2 full rotations. Swabs were put in dry cryovials, immediately placed on ice, and stored for 1-4 h before transferring to a Ϫ70ЊC freezer. Syphilis serology, Gram's stain assessment of cervicitis, Neisseria gonorrhoeae cultures, Chlamydia trachomatis antigen tests, and assessment of cervical ectopy, vaginal candidiasis, trichomoniasis, and bacterial vaginosis were all conducted, as described elsewhere [15] . The presence of cervical, vaginal, or vulvar ulceration was recorded at the time of examination. Physical examination and collection of genital tract samples were conducted by a single investigator (S.B.M.).
Blood tests. Sera were assayed for antibodies to HIV-1 by use of 2 enzyme immunoassays (EIAs; Detect; BioChem ImmunoSystems, Montreal, Canada and Recombigen; Cambridge Biotech, Worchester, MA). Serum samples were tested for HSV-1 and HSV-2 by EIA (Gull Laboratories, Salt Lake City). CD4 ϩ lymphocytes were quantified in EDTA-anticoagulated blood by use of a manual method (Cytosphere; Coulter, Hialeah, FL). Serum samples that had been protected from light were assayed for vitamin A concentration by high-performance liquid chromatography. To assess the potential effect of menstrual cycle hormonal changes on shedding of HSV DNA, we determined serum estradiol and progesterone concentrations for participants who were not pregnant and not using a hormonal form of contraception (Immulite; Diagnostic Products, Los Angeles, CA).
Viral DNA detection. Cervical swabs for viral DNA analysis were shipped to the University of Washington on dry ice and stored at Ϫ70ЊC. The samples were initially prepared and tested for HIV-1 DNA as described elsewhere [15] . Sample lysates from these initial assays were stored at Ϫ70ЊC and tested for HSV DNA by use of a PCR assay, as described elsewhere [12, 16] . PCR primers and probe for HSV detection were directed at the highly conserved common HSV gB gene [16] . The assay was sensitive to the detection of 5 copies of HSV DNA per 20 mL of specimen. For specimens with detectable HSV DNA, the HSV subtype was determined by use of type-specific PCR primers and probes [16] .
Data analysis. Serum vitamin A was divided into 4 commonly used intervals for analysis, representing severe vitamin A deficiency (!20 mg/dL), moderate deficiency (20-29 mg/dL), low-normal (30-39 mg/dL), and high-normal vitamin A status (у40 mg/dL) [17, 18] . For analysis of estradiol and progesterone levels, cut points of 100 pg/mL and 1.0 ng/mL, respectively, were chosen to roughly stratify women into those likely to be in the follicular phase of the menstrual cycle (values less than the cut points) and those likely to be in the luteal phase (values greater than the cut points). We recognize that this is a crude estimate of menstrual cycle intervals. The x 2 , Fisher's exact, and Mann-Whitney U tests were used for univariate comparisons. After the univariate analyses presented in table 1 were performed, logistic regression was used to obtain adjusted estimates for the key predictors of HSV DNA shedding and to determine whether these factors were confounded by other factors that may alter genital tract mucosa or secretions. The variables for contraception/pregnancy, the presence of genital ulceration, and serum vitamin A level were used to form the base model for logistic regression analysis in which the other variables from table 1 were entered one at a time. The added variable was retained in the final model if it substantially changed the strength or magnitude of one of the key predictors, or if it had a P value !.10. No automated procedures were used.
We anticipated at the outset that hormonal contraception, particularly use of oral contraceptive pills, might be an effect modifier of the relationship between serum vitamin A level and HSV shedding. Serum concentrations of vitamin A are known to be elevated in women taking oral contraceptive pills (OCPs), owing to increased mobilization of liver stores, and serum values may not therefore reflect overall vitamin A nutritional status [19] . In evaluating the relationship between serum vitamin A and HSV shedding, we conducted an analysis stratified by contraceptive use (see Results).
Results

Study participants.
Of 314 HIV-1 seropositive women tested, 296 (94.3%) were HSV-1 seropositive, 293 (93.3%) were HSV-2 seropositive, and 275 (87.6%) were seropositive for both viruses. Cervical swabs were available for HSV DNA analysis from 273 of the 275 women who were seropositive for HIV-1, HSV-1, and HSV-2. This analysis focuses on this group of 273 women.
The median age of participants was 28 years (range, 18-46 years). The median number of sex partners in the previous week was 1 (range, 0-6 partners), as was the median frequency of sex in the previous week (range, 0-9). Prevalence of demographic, clinical, and laboratory variables in the study participants are shown in table 1. Of note, 178 (65%) women were using no contraception or nonhormonal forms of contraception (160 used no contraception, 13 had tubal ligation, 5 used an intrauterine device), 30 (11%) women were taking OCPs, 52 (19%) women were using depo-medroxyprogesterone acetate (DMPA), and 11 (4%) women were pregnant. Two women were using levo-norgestrel implants and were excluded from further analyses of contraceptive practices because there were too few to separately assess. In this cohort, 86 (32%) women had serum vitamin A levels consistent with moderate or severe vitamin A deficiency, and 48 (18%) participants had CD4 ϩ lymphocyte counts !200/mL.
Cervical shedding of HSV in the total study group. HSV DNA was detected by PCR in 46 (17%) cervical swabs from 273 women. HSV was subtyped from 38 of the 46 positive swabs; all 38 (100%) were found to be HSV-2. Factors associated with HSV DNA shedding from the cervix are presented in table 1. In univariate analyses, women using OCPs had cervical HSV DNA detected significantly more frequently than women using no contraception or nonhormonal forms of con- traception (30% vs. 11%, ). Cervical shedding of HSV P = .02 was also significantly more frequent in women using DMPA than in the nonhormonal contraceptive group (23% vs. 11%, ). Women who were pregnant at the time of examination P = .03 shed HSV with much greater frequency than women who were not pregnant and not using a hormonal form of contraception (45% vs. 11%, ). P = .007 In the total group of 273 women, participants with severe vitamin A deficiency (!20 mg/dL) had a marginally significant increase in frequency of HSV shedding (table 1). CD4 ϩ lymphocyte count was not significantly associated with detection of HSV DNA. Women with genital ulceration (cervical, vaginal, or vulvar ulcers) at examination shed HSV from the cervix significantly more frequently than women without ulceration (50% vs. 12%, ). None of the other genital tract con-P ! .001 ditions or infections evaluated in this study, including shedding of HIV-1 DNA in cervical secretions, was significantly associated with cervical HSV shedding (table 1) .
Use of OCPs, use of DMPA, current pregnancy, genital ulceration, and serum vitamin A levels were felt to be the key predictors of HSV shedding in univariate analyses and were used to form the base model for logistic regression analysis. Fifteen subsequent regression analyses were conducted in which each of the other variables from a Pregnant women were excluded from this stratified analysis because there were too few to separately assess. b P value for trend (across 4 levels of exposure), . P = .0002 c P value for trend (across 3 levels of exposure), . P = .01 uated with the base model. None of the added variables substantially changed the strength or magnitude of the variables in the base model, and none had a P value !.10; thus, none was retained in the final model shown in table 2. Hormonal contraceptive use, pregnancy, and genital ulceration all remained significantly predictive of cervical HSV shedding. Vitamin A was not significantly associated with HSV shedding in this model; however, as discussed below, there is important effect modification by hormonal contraception in this data.
Cervical HSV shedding in women who were not pregnant and not using a hormonal contraceptive. Stratified analyses of the total study group ( ) revealed that the relationship ben = 273 tween serum vitamin A and HSV shedding was different in women who were not using a hormonal form of contraception than it was in hormonal contraceptive users (i.e., hormonal contraceptive use was found to be an important effect modifier of the association between vitamin A and HSV shedding, table 3). Among the 178 women who were not pregnant and not using a hormonal form of contraception, serum vitamin A levels !20, 20-29, 30-39, and у40 mg/dL were associated with 29%, 18%, 8%, and 2% prevalences of cervical HSV shedding, respectively (test for trend across 4 levels of exposure, P = ). The odds of detecting HSV DNA also increased with .0002 decreasing CD4 lymphocyte count (test for trend, ), al-P = .01 though only women with CD4 counts !200 had a statistically significant increase in odds of HSV shedding (OR, 4.8; 95% CI, 1.1-29.4). Among OCP and DMPA users, there was no significant association between serum vitamin A level or CD4 count and cervical HSV shedding. Figure 1 presents adjusted estimates for serum vitamin A after adjustment for CD4 count by use of logistic regression. Severe vitamin A deficiency, moderate deficiency, and low-normal vitamin A status were associated with 15.6-, 9.8-, and 4.0-fold increased odds of cervical HSV shedding. In this multivariate model, declining CD4 counts were associated with HSV detection, but the association was no longer statistically significant (data not shown). As vitamin A deficiency is known to compromise epithelial integrity [17, 18] , and genital ulceration may therefore lie in the causal pathway between vitamin A levels and HSV shedding, we believed that it would not be appropriate to adjust for genital ulceration in multivariate analysis.
Discussion
Our study of genital HSV shedding in a cohort of HIV-1-infected women documents several novel risk factors for HSV reactivation in the genital tract. To our knowledge, this is the first study of genital HSV shedding to be conducted in the developing world and the first large study to used PCR-based detection of HSV in HIV-1 infected women. We detected HSV DNA in 17% of cervical swabs from 273 women. This prevalence of shedding, based on PCR detection of the virus, is higher than estimates from studies based on culture of the virus in which HSV was isolated on 1%-4% of days [8] [9] [10] . This may, in part, reflect the increased sensitivity of PCR for low copy numbers of the virus, increased frequency of HSV shedding in HIV-1-infected women, and higher prevalence in our cohort of risk factors such as vitamin A deficiency. In a recent study, HSV was cultured more frequently from the genital tract of HIV-1-infected women than from HIV-1-uninfected women at University of Nairobi on July 1, 2014 http://jid.oxfordjournals.org/ Downloaded from Figure 1 . Adjusted odds ratios (ORs) for cervical shedding of herpes simplex virus DNA in women who were not pregnant and not using a hormonal contraceptive. By using multivariate logistic regression, we adjusted indicator variables for serum vitamin A for CD4 ϩ lymphocyte count; univariate associations for both variables are present in table 3. Observations from 177 women were included (178 women were not pregnant and not using a hormonal contraceptive, CD4
ϩ count was missing for one). 95% confidence intervals are within parentheses.
(13.2% vs. 3.6%, respectively) [13] . Data from our study probably underestimate the true prevalence of shedding, as concomitant vulvar and perianal shedding were not evaluated, and addition of swabs from these sites results in increased overall shedding rates in other studies [8, 12] . Use of injected progesterone (DMPA), use of OCPs, and pregnancy were associated with highly significant increased odds of cervical HSV shedding. These exposures are characterized by profound changes in circulating hormone levels. The exogenous hormones in both DMPA and OCPs result in complete suppression of endogenous estradiol and progesterone cycling [20, 21] and alter genital tract physiology to reflect the progestin stimulation [22, 23] . During pregnancy, serum estradiol and progesterone concentrations increase steadily, ultimately reaching levels that are 10-to 100-fold higher than those occurring during normal menstrual cycling [22] .
The increased frequency of HSV shedding in hormonal contraceptive users and pregnant women may reflect direct effects of the hormones on virus replication or effects on the immune system's ability to control virus reactivation. Progesterone has been shown to induce expression of HSV thymidine kinase [24] , and older studies suggest that progesterone enhances HSV replication in tissue culture [25] . Cell-mediated immunity, which is important for control of viral infections, is depressed by both estrogen and progesterone [26, 27] . Both pregnancy and exogenous administration of progesterone have been shown to increase susceptibility to HSV infection in mice [27, 28] . In humans, the frequency of genital herpes recurrences increases in the second and third trimesters of pregnancy [29, 30] , and many HSV seropositive women develop their first clinical episode of genital herpes during pregnancy [31] . Together, these data suggest that elevated levels of the reproductive hormones are permissive for HSV replication, perhaps through more than one mechanism.
Hormonal contraceptive use and pregnancy were important effect modifiers of the association between vitamin A deficiency and HSV shedding. This effect was anticipated for users of OCPs, as serum values of vitamin A in these women are elevated secondary to estrogen-induced mobilization of liver stores, and serum concentrations therefore do not necessarily reflect overall vitamin A status [19] . The potential mechanism for effect modification by DMPA use and pregnancy is less clear. In the 178 women using no hormonal form of contraception, serum vitamin A concentration was a highly significant predictor of cervical HSV shedding. Vitamin A has important and wellrecognized roles in the maintenance and regeneration of epithelial surfaces and in supporting cell-mediated and humoral immune function [17, 18] . Retinoic acid has also been recently reported to suppress replication of HSV-1 in vitro [32] . Other reports in the literature support a biologic basis for the association in our study. In vitamin A-deficient animals, ocular HSV-1 infections have a more rapid and severe course than in control animals [33] . In non-vitamin A-deficient animals with HSV keratitis, vitamin A supplementation was found to speed healing of the epithelial lesions [34] . The association between vitamin A deficiency and genital HSV shedding observed in our study may therefore reflect the vitamin's effect on mucosal integrity, immune function, viral replication, or a combination of the three. This study is limited by the fact that all women were infected with HIV-1. As such, we do not have risk estimates for HSV DNA shedding associated with hormonal contraception and at University of Nairobi on July 1, 2014 http://jid.oxfordjournals.org/ Downloaded from vitamin A deficiency in a group of HIV-1-uninfected women available for direct comparison. Although we cannot think of specific ways in which HIV-1 seropositivity would affect the strong associations observed, we must be cautious about generalizing the results of this study to HIV-1 seronegative women.
In summary, genital tract shedding of HSV was very frequent in this study of HIV-1-seropositive women and was significantly associated with hormonal contraceptive use, pregnancy, and vitamin A deficiency. In light of the continued rise in HSV-2 prevalence in the United States and many other parts of the world, it will be important to further evaluate HSV shedding in hormonal contraceptive users; such studies should include HIV-1-uninfected women and concomitant evaluation of vaginal, vulvar, and perianal shedding. This is the first study, to our knowledge, to evaluate HSV shedding in women from a developing country. Our results suggest that vitamin A deficiency may facilitate sexual transmission of HSV. Prospective studies to evaluate the effect of vitamin A supplementation on genital shedding of HSV appear to be warranted.
